Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 23, 2023 08:30 ET | Source: ReShape Lifesciences Inc

ReShape Lifesciences Announces Formation of International Scientific Advisory Board

SAN CLEMENTE, Calif., March 23, 2023 (GLOBE NEWSWIRE) --  ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the...
March 22, 2023 08:30 ET | Source: ReShape Lifesciences Inc

ReShape Lifesciences® to Announce Financial Results for the Year Ended December 31, 2022, and Provide Corporate Update

SAN CLEMENTE, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that...
March 15, 2023 08:30 ET | Source: ReShape Lifesciences Inc

ReShape Lifesciences® to Present at the Q2 Virtual Investor Summit

SAN CLEMENTE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that...
February 08, 2023 12:07 ET | Source: ReShape Lifesciences Inc

ReShape Lifesciences Announces Closing of Upsized $10.2 Million Underwritten Public Offering

SAN CLEMENTE, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the...
February 06, 2023 08:30 ET | Source: ReShape Lifesciences Inc

ReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offering

SAN CLEMENTE, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the...
December 22, 2022 08:30 ET | Source: ReShape Lifesciences Inc

ReShape Lifesciences Announces 1-for-50 Reverse Stock Split Effective as of Commencement of Trading on December 23, 2022

SAN CLEMENTE, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that...
November 14, 2022 07:30 ET | Source: ReShape Lifesciences Inc

ReShape Lifesciences™ Reports Third Quarter 2022 Financial Results and Provides Corporate Update

SAN CLEMENTE, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported...
November 08, 2022 09:28 ET | Source: ReShape Lifesciences Inc

ReShape Lifesciences Announces $750,000 Registered Direct Offering

SAN CLEMENTE, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that...
November 07, 2022 13:22 ET | Source: ReShape Lifesciences Inc

ReShape Lifesciences™ to Announce Financial Results for the Third Quarter Ended September 30, 2022, and Provide Corporate Update

SAN CLEMENTE, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that...
November 03, 2022 08:30 ET | Source: ReShape Lifesciences Inc

ReShape Lifesciences™ Presents Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at ObesityWeek®

SAN CLEMENTE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right